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Department ofMolecular Biology, Wellcome Research Laboratories, Research Triangle Park, North
Carolina 27709, U.S.A.
Adenylate cyclase is a hormonally responsive membrane-
bound enzyme; many laboratories have attempted to
define the role of lipids in this system (e.g., 1-8). In this
communication we report that adenylate cyclase from rat
brain apparently requires lysophosphatidylcholine or
sphingomyelin for catalytic activity.
METHODS
Male Sprague-Dawley rats were decapitated and their brains removed;
subsequent operations were performed at 0°C. The brain was homoge-
nized in 8 vol (vol/wt) of 3 mM MgCl2, 3 mM DTT, 50 mM Tris-HCl
pH 8.4 and centrifuged for 10 min at 40,000 g,,..,. This procedure was
repeated once and the pellet was homogenized in 8 vol (vol/wt) of 1 mM
MgCl2, I mM DTT, 10%o glycerol (vol/vol), 0.5% sodium deoxycholate
(DOC), 50 mM Tris-HCI, pH 8.4 (Buffer A). The homogenate was
centrifuged for 45 min at 300,000 g,..., and the supernatant, containing
solubilized enzyme, retained. Enzyme in the supernatant was separated
from solubilized lipid by chromatography on Ultrogel AcA34 equili-
brated with buffer A. When required, phospholipid, dissolved in chloro-
form:methanol (2:1 vol/vol) and dried under a stream of N2, was
dispersed in the solubilized enzyme preparation. Enzyme activity was
measured at 300C (10).
RESULTS AND DISCUSSION
Adenylate cyclase solubilized with 0.5% DOC from rat
brain has essentially no enzymic activity (Table I), but full
activity can be restored by the addition of phosphatidyl-
choline. If the mixture of enzyme and phospholipid is
diluted and the lipid vesicles collected by ultracentrifuga-
tion, they are found to contain all of the adenylate cyclase
activity (9). The ability of enzyme to become lipid asso-
ciated has been noted previously and extensively charac-
terized for a preparation solubilized with Nonidet P40
(10). The incorporation of solubilized enzyme into lipo-
somes suggests either that adenylate cyclase has a hydro-
phobic membrane-binding domain or that it is cosolubi-
lized with a hydrophobic protein to which it can attach.
The possession of a hydrophobic region raises the possibil-
ity that lipids may be capable of regulating enzyme
activity. To investigate this possibility, the effect of various
phospholipids on the activity of DOC-solubilized enzyme
was investigated.
In addition to phosphatidylcholine, nonionic detergent,
sphingomyelin, lysophosphatidylcholine or phosphatidyl-
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N-methylethanolamine can restore full activity to the
DOC-solubilized enzyme. Partial activity was restored by
phosphatidylethanolamine or phosphatidyl-NN-dimethyl-
ethanolamine (Fig. 1 A). All other lipids tested were
without effect when added alone, and when added with
phosphatidylcholine they generally inhibited reconstitu-
tion (9).
The DOC-solubilized adenylate cyclase preparation
contains lipids solubilized from the brain with the enzyme,
which complicates the analysis. To exclude this interfer-
ence, the solubilized preparation was delipidated by gel
filtration. Maximal activity was restored to this prepara-
tion by lysophosphatidylcholine. Sphingomyelin, when
mixed with phosphatidylcholine, will also activate; below
75 mol % the extent of activation is directly proportional to
the sphingomyelin concentration. At higher concentrations
the physical state of the lipid suspension changes, becom-
ing more particulate, which may account for the lower
activity observed. Phosphatidylcholine and Triton X-100
partially reconstitute activity (Fig. 1 B). All other lipids
tested were unable to reconstitute activity and inhibited
the stimulation observed with lysophosphatidylcholine or
sphingomyelin.
TABLE I
SOLUBILIZATION OF ADENYLATE CYCLASE FROM RAT
BRAIN AND INCORPORATION INTO LIPOSOMES
Adenylate cyclase Protein
activity concentration
pmol min- ' mg ml
Original brain homogenate 17.0 13.0
Deoxycholate supernatant 0.5 5.1
Deoxycholate pellet 1.3 7.9
Deoxycholate supernatant
+ phosphatidylcholine 36.5 5.1
Liposomes 45.5 3.0
Rat brain was homogenized and extracted with DOC as described in
Methods. Phosphatidylcholine (10 mg ml-') was dispersed in the solubi-
lized enzyme preparation, the mixture was diluted -20-40-fold, and lipo-
somes were collected by centrifugation (300,000 g.,, for I h). All samples
were resuspended to equivalent volumes, and aliquots were assayed for
adenylate cyclase activity.
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FIGURE 1 Phospholipid specificity of adenylate cyclase activation
before and after delipidation. Solubilized adenylate cyclase before (A) or
after (B) delipidation was assayed with phospholipid (10 mg ml-' in
assay) or Triton X-1I00.
In conclusion, these results suggest adenylate cyclase
has a specific phospholipid requirement for catalytic activ-
ity. Changing the lipid environment of the enzyme might
well be a mechanism whereby activity is normally modu-
lated by hormones, by changes in the metabolic status of
the cell, or during differentiation. Many possible mecha-
nisms exist for effecting changes in the lipid environment
of the enzyme. For example, exchanging an inhibitory for
a stimulatory lipid by a phospholipid exchange protein or
hydrolyzing phosphatidylcholine to produce lysophospha-
tidylcholine can both be predicted to activate adenylate
cyclase. These and other possibilities are currently under
investigation.
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The enzyme 3-hydroxy-3-methylglutaryl coenzyme A
reductase (HMG-CoA reductase) catalyzes the rate-limit-
ing reaction of hepatic cholesterol synthesis under most
physiological conditions (Rodwell et al., 1976). The
enzyme is unique among the early enzymes of the pathway
in that it is bound to the endoplasmic reticulum in vivo.
This gives rise to the potential regulation of the enzyme
through interactions with the membrane lipids. Interac-
tions between membrane bound proteins and lipid compo-
nents has been the subject of several recent reviews (Lenaz
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